1-6 of 6
Authors: Catherine Hewison
Journal Article
The Frequency and Incidence of QT Prolongation With Extended Use of Bedaquiline or Delamanid in a Large, Multi-Country MDR/RR-TB Cohort Open Access
Clinical Infectious Diseases, ciae601, https://doi.org/10.1093/cid/ciae601
Published: 10 December 2024
Journal Article
Estimating Post-treatment Recurrence After Multidrug-Resistant Tuberculosis Treatment Among Patients With and Without Human Immunodeficiency Virus: The Impact of Assumptions About Death and Missing Follow-up Open Access
Clinical Infectious Diseases, Volume 78, Issue 1, 15 January 2024, Pages 164–171, https://doi.org/10.1093/cid/ciad589
Published: 29 September 2023
Journal Article
Pregnancy and Birth Outcomes in Patients With Multidrug-Resistant Tuberculosis Treated With Regimens That Include New and Repurposed Drugs Open Access
Clinical Infectious Diseases, Volume 78, Issue 1, 15 January 2024, Pages 144–148, https://doi.org/10.1093/cid/ciad445
Published: 22 August 2023
Journal Article
Safety and Effectiveness Outcomes From a 14-Country Cohort of Patients With Multi-Drug Resistant Tuberculosis Treated Concomitantly With Bedaquiline, Delamanid, and Other Second-Line Drugs Open Access
Clinical Infectious Diseases, Volume 75, Issue 8, 15 October 2022, Pages 1307–1314, https://doi.org/10.1093/cid/ciac176
Published: 04 March 2022
Journal Article
Safety of Treatment Regimens Containing Bedaquiline and Delamanid in the endTB Cohort Open Access
Clinical Infectious Diseases, Volume 75, Issue 6, 15 September 2022, Pages 1006–1013, https://doi.org/10.1093/cid/ciac019
Published: 13 January 2022
Journal Article
Culture Conversion at 6 Months in Patients Receiving Delamanid-containing Regimens for the Treatment of Multidrug-resistant Tuberculosis Free
Clinical Infectious Diseases, Volume 71, Issue 2, 15 July 2020, Pages 415–418, https://doi.org/10.1093/cid/ciz1084
Published: 02 November 2019
